Clinical trials demonstrated decreasing rates of bronchopulmonary dysplasia in preterm infants with hypoxic respiratory failure treated with inhaled nitric oxide (iNO). However, the molecular and ...
Infants with bronchiolitis who received 150 ppm inhaled nitric oxide plus standard supportive treatment had shorter hospital stays and improved respiratory outcomes, according to results published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback